Merus Labs International Inc (USA) news

   Watch this stock
Showing stories 1 - 10 of about 11   

Articles published

MSLI 1.55 -0.08 (-4.91%)
price chart
Merus Labs International Inc.: Completes $20 Million Bought Deal Financing
TORONTO, ONTARIO--(Marketwired - March 25, 2014) - Merus Labs International Inc. ("Merus" or the "Company") (TSX:MSL)(NASDAQ:MSLI) is pleased to announce today the closing of its previously announced bought deal financing with a syndicate of investment ...
Related articles »  
Merus Labs Names Barry Fishman as Senior Advisor
TORONTO, ONTARIO, Apr 23, 2014 (Marketwired via COMTEX) -- Merus Labs International Inc. ("Merus" or the "Company") (TOR:CA:MSL) (NASDAQ:MSLI) , a Canadian publicly traded specialty pharmaceutical company, announced today that Barry Fishman has joined ...
Related articles »  
Merus Labs International Inc. Announces Closing on Full Exercise of Over ...
TORONTO, ONTARIO--(Marketwired - March 31, 2014) - Merus Labs International Inc. ("Merus" or the "Company") (TSX:MSL)(NASDAQ:MSLI) is pleased to announce today that the syndicate of investment dealers (the "Underwriters") has exercised in full the over ...
Related articles »  
Merus Labs International Inc Announces Board Change